Helsinn Group Announces new Permanent J Code for AKYNZEO® (fosnetupitant and palonosetron) for injection in the US

12 December 2018

Wound care: Nexodyn® AOS comes to fruition in Slovakia

12 December 2018

Helsinn and Mundipharma China Pharmaceutical Announce Approval of ALOXI® IV by the National Medical Products Administration (NMPA)Helsinn and Mundipharma China Pharmaceutical Announce Approval of ALOXI® IV by the National Medical Products Administration (NMPA)

3 December 2018

PKU GOLIKE® comes to fruition in Italy

29 November 2018

La farmaceutica ticinese a Madrid per la CPhI 2018

28 November 2018

Paolo Magri nominated as President of the Board of Directors of the Drug, Chemical & Associated Technologies Association (DCAT)

14 November 2018

Rare Diseases: Expected Benefits of a Physiological Absorption of Amino Acids in PKU management. PKU GOLIKE® by APR can play a role

6 November 2018

Helsinn Group supports Satellite Symposium at 14th EADO Congress 2018

6 November 2018

Farma Industria Ticino and Ticino’s pharmaceutical companies in Madrid for CPhI Worldwide 2018

31 October 2018

Cigalah Medpharm announces the launch in Saudi Arabia and United Arab Emirates of Nexodyn® AOS, the Tehclo-based wound cleanser developed by the Swiss Pharma Company APR

18 October 2018